Mazkeret-Batya, Israel

Flavio Grynszpan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pharmos Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Flavio Grynszpan. Retrieved from https://idiyas.com/inventor/flavio-grynszpan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Flavio Grynszpan: Innovator in Sulfonamide Derivatives

Introduction

Flavio Grynszpan is a notable inventor based in Mazkeret Batia, Israel. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on sulfonamide derivatives.

Latest Patents

Grynszpan holds a patent for sulfonamide compounds, which are defined by a specific formula. His invention provides pharmaceutical compositions containing these compounds and outlines methods of treatment utilizing them. These sulfonamide derivatives are recognized for their wide range of beneficial therapeutic indications, especially as analgesic and anti-inflammatory agents. He has 1 patent to his name.

Career Highlights

Flavio Grynszpan is associated with Pharmos Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the understanding and application of sulfonamide compounds in medical treatments.

Collaborations

Grynszpan has collaborated with notable colleagues, including Avihai Yacovan and Iris Alroy, to further enhance the impact of his research and innovations in the pharmaceutical industry.

Conclusion

Flavio Grynszpan's contributions to the field of pharmaceuticals through his innovative sulfonamide derivatives highlight his role as a significant inventor. His work continues to influence therapeutic practices and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…